Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
Monster Beverage
MNST
|
+$584M |
| 3 |
Intercontinental Exchange
ICE
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$386M |
| 5 |
Johnson & Johnson
JNJ
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$750M |
| 3 |
Deere & Co
DE
|
+$539M |
| 4 |
Microsoft
MSFT
|
+$507M |
| 5 |
Meta Platforms (Facebook)
META
|
+$488M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.99% |
| 2 | Healthcare | 19.86% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.49% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Vanguard FTSE Europe ETF
VGK
$30.3B
| $52.6M | 0.03% |
739,574
-15,576
| -2% | -$1.07M |
|
377
Innospec
IOSP
$2.09B
| $52.4M | 0.03% |
463,411
-90,810
| -16% | -$10.6M |
|
378
Coca-Cola Europacific Partners
CCEP
$49.1B
| $52.4M | 0.03% |
+664,945
| New | +$51M |
|
379
Waste Management
WM
$95.4B
| $52.2M | 0.03% |
251,355
-840
| -0.3% | -$175K |
|
380
Nordson
NDSN
$16.5B
| $52.1M | 0.03% |
198,238
+79
| +0% | +$19.3K |
|
381
CG Oncology
CGON
$6.13B
| $51.9M | 0.03% |
1,526,534
+99,517
| +7% | +$3.49M |
|
382
Walmart Inc
WMT
$910B
| $51.8M | 0.03% |
641,111
-153
| -0% | -$11.2K |
|
383
Immunome
IMNM
$2.66B
| $51M | 0.03% |
3,488,121
+324,614
| +10% | +$4.61M |
|
|
MREO
384
Mereo BioPharma
MREO
$52.3M
| $50.9M | 0.03% |
12,345,866
+4,464,984
| +57% | +$18.5M |
|
385
The Bancorp
TBBK
$2.82B
| $50.8M | 0.03% |
949,955
-4,375
| -0.5% | -$211K |
|
386
Sanofi
SNY
$108B
| $50.8M | 0.03% |
881,682
+92,015
| +12% | +$4.97M |
|
|
EXE
387
Expand Energy Corp
EXE
$22.1B
| $50.5M | 0.03% |
614,102
+4,600
| +0.8% | +$351K |
|
388
Graphic Packaging
GPK
$3.31B
| $50.2M | 0.03% |
1,697,512
+76,313
| +5% | +$2.17M |
|
389
Williams-Sonoma
WSM
$27.6B
| $49.9M | 0.03% |
322,249
-323,411
| -50% | -$46.4M |
|
390
Royalty Pharma
RPRX
$26.4B
| $49.9M | 0.03% |
1,763,245
-4,172
| -0.2% | -$116K |
|
391
Brady Corp
BRC
$4.49B
| $49.6M | 0.03% |
647,085
-6,670
| -1% | -$475K |
|
|
CRGX
392
DELISTED
CARGO Therapeutics
CRGX
| $49.3M | 0.03% |
2,675,285
+46,659
| +2% | +$835K |
|
393
Wyndham Hotels & Resorts
WH
$5.6B
| $49.1M | 0.03% |
628,521
+27,172
| +5% | +$2.06M |
|
394
Entegris
ENTG
$16.9B
| $48.7M | 0.02% |
432,389
+404
| +0.1% | +$47.8K |
|
|
CWAN
395
DELISTED
Clearwater Analytics
CWAN
| $48.2M | 0.02% |
1,906,929
+1,819
| +0.1% | +$40.9K |
|
396
Ball Corp
BALL
$17.5B
| $48M | 0.02% |
707,279
+87,577
| +14% | +$5.56M |
|
397
CVS Health
CVS
$136B
| $47.8M | 0.02% |
760,903
+599,200
| +371% | +$35M |
|
398
Fortune Brands Innovations
FBIN
$5.88B
| $47.8M | 0.02% |
534,029
-67,892
| -11% | -$5.21M |
|
|
SW
399
Smurfit Westrock
SW
$25.2B
| $47.4M | 0.02% |
+945,572
| New | +$43M |
|
400
TC Energy
TRP
$69.9B
| $47.3M | 0.02% |
994,077
-226
| -0% | -$9.82K |
|
Similar funds
Janus Henderson Group's Q3 2024 Portfolio in Review
As of Q3 2024, Janus Henderson Group held 2,584 positions worth $195B, up 4.6% from $187B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.7%. Janus Henderson Group opened 66 new positions and exited 56, leaving the 2,584-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2024 buy was Janus Henderson Emerging Markets Debt Hard Currency ETF: 4,369,165 shares worth $228M.
- Janus Henderson Group added most to Broadcom in Q3 2024, an estimated $605M increase.
- Janus Henderson Group's biggest Q3 2024 reduction was Texas Instruments, cutting an estimated $750M.
- Janus Henderson Group fully exited Lam Research in Q3 2024, selling an estimated $1.95B.
- Janus Henderson Group's ten largest holdings make up 30% of its $195B portfolio in Q3 2024.
- Janus Henderson Group opened 66 new positions and closed 56 in Q3 2024.
- Janus Henderson Group's portfolio value rose 4.6% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.